Howard Ho-Fung Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Howard Ho-Fung Tang has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Michael Inouye
British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
6 shared publications Shu Mei Teo
Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Australia; Cambridge Baker Systems Genomics Initiative, University of Cambridge, Cambridge, United Kingdom
5 shared publications- Patrick G. Holt
Wal-yan Respiratory Research Centre, The Kids Research Institute Australia, Nedlands, Western Australia, Australia.
3 shared publications Peter D. Sly
Child Health Research Centre, The University of Queensland, Brisbane, Australia
3 shared publicationsJames E. Gern
University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA
2 shared publicationsKathryn E. Holt
Dept of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Australia
2 shared publications
Latest Publications
- Open Access
The gut microbiome is a significant risk factor for future chronic lung disease
Background The gut-lung axis is generally recognized, but there are few large studies of the gut microbiome and incident respiratory disease in adults. Objectives3 To investigate the associations between gut microbiome and respiratory disease and to construct predictive models from baseline gut microbiome profiles for incident asthma or chronic obstructive pulmonary disease (COPD). Methods Shallow metagenomic sequencing was performed for stool samples from a prospective, population-based cohort (FINRISK02; N=7,115 adults) with linked national administrative health register derived classifications for incident asthma and COPD up to 15 years after baseline. Generalised linear models and Cox regressions were utilised to assess associations of microbial taxa and diversity with disease occurrence. Predictive models were constructed using machine learning with extreme gradient boosting. Models considered taxa abundances individually and in combination with other risk factors, including sex, age, body mass index and smoking status. Results A total of 695 and 392 significant microbial associations at different taxonomic levels were found with incident asthma and COPD, respectively. Gradient boosting decision trees of baseline gut microbiome predicted incident asthma and COPD with mean area under the curves of 0.608 and 0.780, respectively. For both incident asthma and COPD, the baseline gut microbiome had C-indices of 0.623 for asthma and 0.817 for COPD, which were more predictive than other conventional risk factors. The integration of gut microbiome and conventional risk factors further improved prediction capacities. Subgroup analyses indicated gut microbiome was significantly associated with incident COPD in both current smokers and non-smokers, as well as in individuals who reported never smoking. Conclusions The gut microbiome is a significant risk factor for incident asthma and incident COPD and is largely independent of conventional risk factors.
Open AccessThe gut microbiome is a significant risk factor for future chronic lung disease
Background The gut-lung axis is generally recognized, but there are few large studies of the gut microbiome and incident respiratory disease in adults. Objectives3 To investigate the associations between gut microbiome and respiratory disease and to construct predictive models from baseline gut microbiome profiles for incident asthma or chronic obstructive pulmonary disease (COPD). Methods Shallow metagenomic sequencing was performed for stool samples from a prospective, population-based cohort (FINRISK02; N=7,115 adults) with linked national administrative health register derived classifications for incident asthma and COPD up to 15 years after baseline. Generalised linear models and Cox regressions were utilised to assess associations of microbial taxa and diversity with disease occurrence. Predictive models were constructed using machine learning with extreme gradient boosting. Models considered taxa abundances individually and in combination with other risk factors, including sex, age, body mass index and smoking status. Results A total of 695 and 392 significant microbial associations at different taxonomic levels were found with incident asthma and COPD, respectively. Gradient boosting decision trees of baseline gut microbiome predicted incident asthma and COPD with mean area under the curves of 0.608 and 0.780, respectively. For both incident asthma and COPD, the baseline gut microbiome had C-indices of 0.623 for asthma and 0.817 for COPD, which were more predictive than other conventional risk factors. The integration of gut microbiome and conventional risk factors further improved prediction capacities. Subgroup analyses indicated gut microbiome was significantly associated with incident COPD in both current smokers and non-smokers, as well as in individuals who reported never smoking. Conclusions The gut microbiome is a significant risk factor for incident asthma and incident COPD and is largely independent of conventional risk factors.
- 1 March 2021
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 147 (3) , 781-793
The intersect of genetics, environment, and microbiota in asthma—perspectives and challenges
- 1 March 2021
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 147 (3) , 781-793
The intersect of genetics, environment, and microbiota in asthma—perspectives and challenges
- 1 December 2019
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 105 (6) , 1076-1090
Multivariate Genome-wide Association Analysis of a Cytokine Network Reveals Variants with Widespread Immune, Haematological, and Cardiometabolic Pleiotropy
- 1 December 2019
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 105 (6) , 1076-1090
Multivariate Genome-wide Association Analysis of a Cytokine Network Reveals Variants with Widespread Immune, Haematological, and Cardiometabolic Pleiotropy
- 16 October 2019
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 55 (1) , 1900844
Systems biology and big data in asthma and allergy: recent discoveries and emerging challenges
Asthma is a common condition caused by immune and respiratory dysfunction, and it is often linked to allergy. A systems perspective may prove helpful in unravelling the complexity of asthma and allergy. Our aim is to give an overview of systems biology approaches used in allergy and asthma research. Specifically, we describe recent “omic”-level findings, and examine how these findings have been systematically integrated to generate further insight.Current research suggests that allergy is driven by genetic and epigenetic factors, in concert with environmental factors such as microbiome and diet, leading to early-life disturbance in immunological development and disruption of balance within key immuno-inflammatory pathways. Variation in inherited susceptibility and exposures causes heterogeneity in manifestations of asthma and other allergic diseases. Machine learning approaches are being used to explore this heterogeneity, and to probe the pathophysiological patterns or “endotypes” that correlate with subphenotypes of asthma and allergy. Mathematical models are being built based on genomic, transcriptomic and proteomic data to predict or discriminate disease phenotypes, and to describe the biomolecular networks behind asthma.The use of systems biology in allergy and asthma research is rapidly growing, and has so far yielded fruitful results. However, the scale and multidisciplinary nature of this research means that it is accompanied by new challenges. Ultimately, it is hoped that systems medicine, with its integration of omics data into clinical practice, can pave the way to more precise, personalised and effective management of asthma.
- 16 October 2019
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 55 (1) , 1900844
Systems biology and big data in asthma and allergy: recent discoveries and emerging challenges
Asthma is a common condition caused by immune and respiratory dysfunction, and it is often linked to allergy. A systems perspective may prove helpful in unravelling the complexity of asthma and allergy. Our aim is to give an overview of systems biology approaches used in allergy and asthma research. Specifically, we describe recent “omic”-level findings, and examine how these findings have been systematically integrated to generate further insight.Current research suggests that allergy is driven by genetic and epigenetic factors, in concert with environmental factors such as microbiome and diet, leading to early-life disturbance in immunological development and disruption of balance within key immuno-inflammatory pathways. Variation in inherited susceptibility and exposures causes heterogeneity in manifestations of asthma and other allergic diseases. Machine learning approaches are being used to explore this heterogeneity, and to probe the pathophysiological patterns or “endotypes” that correlate with subphenotypes of asthma and allergy. Mathematical models are being built based on genomic, transcriptomic and proteomic data to predict or discriminate disease phenotypes, and to describe the biomolecular networks behind asthma.The use of systems biology in allergy and asthma research is rapidly growing, and has so far yielded fruitful results. However, the scale and multidisciplinary nature of this research means that it is accompanied by new challenges. Ultimately, it is hoped that systems medicine, with its integration of omics data into clinical practice, can pave the way to more precise, personalised and effective management of asthma.
- Open Access
- 15 October 2018
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 7
Trajectories of childhood immune development and respiratory health relevant to asthma and allergy
Events in early life contribute to subsequent risk of asthma; however, the causes and trajectories of childhood wheeze are heterogeneous and do not always result in asthma. Similarly, not all atopic individuals develop wheeze, and vice versa. The reasons for these differences are unclear. Using unsupervised model-based cluster analysis, we identified latent clusters within a prospective birth cohort with deep immunological and respiratory phenotyping. We characterised each cluster in terms of immunological profile and disease risk, and replicated our results in external cohorts from the UK and USA. We discovered three distinct trajectories, one of which is a high-risk ‘atopic’ cluster with increased propensity for allergic diseases throughout childhood. Atopy contributes varyingly to later wheeze depending on cluster membership. Our findings demonstrate the utility of unsupervised analysis in elucidating heterogeneity in asthma pathogenesis and provide a foundation for improving management and prevention of childhood asthma.
- 15 October 2018
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 7
Open AccessTrajectories of childhood immune development and respiratory health relevant to asthma and allergy
Events in early life contribute to subsequent risk of asthma; however, the causes and trajectories of childhood wheeze are heterogeneous and do not always result in asthma. Similarly, not all atopic individuals develop wheeze, and vice versa. The reasons for these differences are unclear. Using unsupervised model-based cluster analysis, we identified latent clusters within a prospective birth cohort with deep immunological and respiratory phenotyping. We characterised each cluster in terms of immunological profile and disease risk, and replicated our results in external cohorts from the UK and USA. We discovered three distinct trajectories, one of which is a high-risk ‘atopic’ cluster with increased propensity for allergic diseases throughout childhood. Atopy contributes varyingly to later wheeze depending on cluster membership. Our findings demonstrate the utility of unsupervised analysis in elucidating heterogeneity in asthma pathogenesis and provide a foundation for improving management and prevention of childhood asthma.
- Top Cited Papers
- 1 September 2018
- Published by Elsevier in Cell Host & Microbe
- Vol. 24 (3) , 341-352.e5
Airway Microbiota Dynamics Uncover a Critical Window for Interplay of Pathogenic Bacteria and Allergy in Childhood Respiratory Disease
- 1 September 2018
- Published by Elsevier in Cell Host & Microbe
- Vol. 24 (3) , 341-352.e5
Top Cited PapersAirway Microbiota Dynamics Uncover a Critical Window for Interplay of Pathogenic Bacteria and Allergy in Childhood Respiratory Disease
- 1 February 2018
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 141 (2) , AB109
Nasopharyngeal Microbiome During Health and Illness in Early Life
- 1 February 2018
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 141 (2) , AB109
Nasopharyngeal Microbiome During Health and Illness in Early Life
- 1 January 2017
- Published by Medknow in Indian Journal of Public Health
- Vol. 61 (2) , 137-140
Use of skin-lightening products among outpatient attendees in a North Indian Hospital
Pattern of skin lighter use. Demographics, pattern of skin lightener use and incidence of side effects, perceptions of lighter skin tones were the main outcomes and measures studied. The use of skin lighteners was highly prevalent in our study population. Believing that lighter skin is beneficial for self-esteem is a predictor for skin lightener use. Higher education was associated with lower perceived benefits of fairer skin and therefore reduced skin lightener use. Further education and increased community awareness are important to address the issues surrounding potential over-use of skin-lightening products....
- 1 January 2017
- Published by Medknow in Indian Journal of Public Health
- Vol. 61 (2) , 137-140
Use of skin-lightening products among outpatient attendees in a North Indian Hospital
Pattern of skin lighter use. Demographics, pattern of skin lightener use and incidence of side effects, perceptions of lighter skin tones were the main outcomes and measures studied. The use of skin lighteners was highly prevalent in our study population. Believing that lighter skin is beneficial for self-esteem is a predictor for skin lightener use. Higher education was associated with lower perceived benefits of fairer skin and therefore reduced skin lightener use. Further education and increased community awareness are important to address the issues surrounding potential over-use of skin-lightening products....
- 7 March 2016
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 33, 210-219
Axillary Artery Injury Associated with Proximal Humeral Fractures: Review of Long-Term Vascular, Orthopedic, and Neurologic Outcomes
- 7 March 2016
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 33, 210-219
Axillary Artery Injury Associated with Proximal Humeral Fractures: Review of Long-Term Vascular, Orthopedic, and Neurologic Outcomes
- 15 February 2016
- Published by AMPCo in Medical Journal of Australia
- Vol. 204 (3) , 114
Emergency department presentations with mammalian bite injuries: risk factors for admission and surgery
Further analysis of surgical findings in patients who have sustained bite injuries is needed
- 15 February 2016
- Published by AMPCo in Medical Journal of Australia
- Vol. 204 (3) , 114
Emergency department presentations with mammalian bite injuries: risk factors for admission and surgery
Further analysis of surgical findings in patients who have sustained bite injuries is needed